Details:

Alternative Title:
J Pediatr
Publisher's site:
http://dx.doi.org/10.1016/j.jpeds.2015.02.018
Personal Author:
Visser, Susanna N. ; Bitsko, Rebecca H. ; Danielson, Melissa L. ; Gandhour, Reem ; Blumberg, Stephen J. ; ... More +
Visser, Susanna N. ; Bitsko, Rebecca H. ; Danielson, Melissa L. ; Gandhour, Reem ; Blumberg, Stephen J. ; Schieve, Laura ; Holbrook, Joseph ; Wolraich, Mark ; Cuffe, Steven Less -
Description:
Objective

Describe the parent-reported prevalence of ADHD treatments among a national sample of children with special health care needs (CSHCN), and assess the alignment of ADHD treatment to current American Academy of Pediatrics (AAP) guidelines.

Methods

Parent-reported data from the 2009–10 National Survey of Children with Special Health Care Needs allowed for weighted national and state-based prevalence estimates of medication, behavioral therapy, and dietary supplement use for ADHD treatment among CSHCN, aged 4–17 years with current ADHD. National estimates were compared across demographic groups, ADHD severity, and comorbidities. Medication treatment by drug class was described.

Results

Of CSHCN with current ADHD, 74.0% had past week medication treatment and 44.0% had past year behavioral therapy. In the past year, 10.2% used dietary supplements for ADHD. Overall, 87.3% had received past week medication treatment or past year behavioral therapy (both=30.7%, neither=12.7%). Among preschool-aged CSHCN with ADHD, 25.4% received medication treatment alone, 31.9% received behavioral therapy alone, 21.2% received both treatments, and 21.4% received neither treatment. Central nervous system stimulants were the most common medication class (84.8%) among CSHCN with ADHD, followed by the selective norepinephrine reuptake inhibitor atomoxetine (8.4%).

Conclusions

These estimates benchmark clinical practice for the period directly preceding the AAP’s 2011 ADHD guidelines. Most children with ADHD received medication treatment or behavioral therapy; just under one-third received both. Multi-modal treatment was most common among CSHCN with severe ADHD and those with comorbidities. About half of preschoolers received behavioral therapy, the recommended first-line treatment for this age group.


Subject:
[+]
Adolescent Article Attention Deficit Disorder With Hyperactivity Behavioral Therapy Child Child, Preschool Child Health Services Combined Modality Therapy Epidemiology Female Health Services Needs And Demand Humans Male Medication Treatment Public Health
Source:
J Pediatr. 166(6):1423-1430.e2
Pubmed ID:
25841538
Pubmed Central ID:
PMC4469986
Document Type:
Journal Article
Funding:
CC999999/Intramural CDC HHS/United States
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:b0e039a3dff4515bef221571c2541d90324b11a092e9d791dc24482da1ad1962
Download URL:
https://stacks.cdc.gov/view/cdc/31660/cdc_31660_DS1.pdf
File Type:

Supporting Files

• 	NIHMS699111-supplement-T1.docx	docx
  	nihms699111.nxml	xml
  	nihms699111f1.gif	gif
  	nihms699111f1.jpg	jpeg
  	nihms699111f2.gif	gif
  	nihms699111f2.jpg	jpeg
  	nihms699111f3.gif	gif
  	nihms699111f3.jpg	jpeg

More +